|
DEB
MCID: EPD009
|
Epidermolysis Bullosa Dystrophica malady |
|
Sources: 17Genetics Home Reference, 44Wikipedia, 15GeneReviews, 22MalaCards See all sources Export this MalaCard |
Genetics Home Reference: Epidermolysis bullosa is a group of genetic conditions that cause the skin to be very fragile and to blister easily. Blisters and skin erosions form in response to minor injury or friction, such as rubbing or scratching. Dystrophic epidermolysis bullosa (DEB) is one of the major forms of epidermolysis bullosa. The signs and symptoms of this condition vary widely among affected individuals. In mild cases, blistering may primarily affect the hands, feet, knees, and elbows. Severe cases of this condition involve widespread blistering that can lead to vision loss, disfigurement, and other serious medical problems.17
MalaCards: Epidermolysis Bullosa Dystrophica, also known as dystrophic epidermolysis bullosa, is related to recessive dystrophic epidermolysis bullosa and epidermolysis bullosa pruriginosa. An important gene associated with Epidermolysis Bullosa Dystrophica is COL7A1 (collagen, type VII, alpha 1), and among its related pathways are Activation of Matrix Metalloproteinases and Inhibition of Matrix Metalloproteinases. The drugs phenytoin sodium,prompt and phenytoin sodium extended and the compounds (4-aminophenyl)mercuric acetate and astacin have been mentioned in the context of this disorder. Affiliated tissues include skin. Wikipedia: Epidermolysis bullosa dystrophica or Dystrophic EB (DEB) is an inherited disease affecting the skin and...44 more... GeneReviews summary for ebd |
|
Sources: 6Disease Ontology, 7diseasecard, 15GeneReviews, 30NIH Rare Diseases, 16GeneTests, 17Genetics Home Reference, 8DISEASES, 43UMLS, 32Novoseek , 40SNOMED-CT, 24MeSH, 27NCIt See all sources |
|
|
|
Sources: 4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 21LifeMap Discovery™, 43UMLS, 28NDF-RT See all sources |
Approved drugs:Search CenterWatch for epidermolysis bullosa dystrophica Drug clinical trials:Search ClinicalTrials for epidermolysis bullosa dystrophica Search NIH Clinical Center for epidermolysis bullosa dystrophica Search CenterWatch for epidermolysis bullosa dystrophica Inferred drug relations via UMLS/NDF-RT:43 28 phenytoin, phenytoin sodium, phenytoin sodium extended, phenytoin sodium,extended, phenytoin sodium,promptCell-based therapeutics:![]() The database of embryonic development, stem cell research and regenerative medicine Stem-Cell-Based therapeutic approaches for epidermolysis bullosa dystrophica:
|
|
Sources: 16GeneTests See all sources |
|
Sources: 22MalaCards See all sources |
MalaCards organs/tissues related to epidermolysis bullosa dystrophica:22Skin
|
|
|
|
Sources: 35PubMed See all sources |
Articles related to epidermolysis bullosa dystrophica:
|
|
Sources: 1BioGPS See all sources |
![]() |
|
Sources: 38Reactome, 36QIAGEN, 10EMD Millipore, 41Thomson Reuters See all sources |
Pathways related to epidermolysis bullosa dystrophica according to GeneDecks:
|
|
Sources: 32Novoseek , 42Tocris Bioscience, 9DrugBank See all sources |
Compounds related to epidermolysis bullosa dystrophica according to GeneDecks:
|
|
Sources: 12Gene Ontology See all sources |
Cellular components related to epidermolysis bullosa dystrophica according to GeneDecks:
Biological processes related to epidermolysis bullosa dystrophica according to GeneDecks:
Molecular functions related to epidermolysis bullosa dystrophica according to GeneDecks:
|

